SwanBio Advances to Higher-Dose Cohort in First-in-Human Study of Gene Therapy for Adrenomyeloneuropathy
PHILADELPHIA--(BUSINESS WIRE)--Oct 4, 2023--
Stay updated with breaking news from Syncona Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PHILADELPHIA--(BUSINESS WIRE)--Oct 4, 2023--
Independent Data Safety Monitoring Board recommended dose escalation First patient in cohort 2 has received SBT101 Majority investor Syncona providing new...
Syncona Ltd - London-based investor in healthcare companies - Launches share buyback programme worth up to GBP40.0 million, to be conducted by Numis Securities Ltd. Says core focus remains on...
Purespring appoints Fredrik Erlandsson as Chief Medical Officer and Peter Mulcahy as Chief People Officer Appointments of Fredrik and Peter complete build-out of senior team London— 6 September 2023— Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of kidney diseases, has appointed Fredrik Erlandson as Chief Medical Officer and Peter Mulcahy as Chief People Officer. These two key additional appointments complete Purespring’s leadership team, fillin
Appointments of Fredrik and Peter complete build-out of senior team London- 6 September 2023- Purespring Therapeutics, a pioneering gene therapy company focused on transforming...